Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Nik-related protein kinase (NRK) is a human protein kinase encoded by the NRK gene, functioning primarily as an enzyme catalyzing protein phosphorylation[1][2][3][6]. It belongs to the MSN subfamily of kinases and is classified within the germinal center kinase IV family[2][4]. NRK plays a role in signal transduction, notably in the TNF-alpha pathway and by suppressing Akt signaling[3][4]. It is involved in embryonic development, actin polymerization (likely through cofilin-1), and may be important for proper placental formation[4]. Mutations or dysregulation of NRK have been associated with hypermobility syndrome and studied in the context of hyperplastic prostate tissue[3][5]. Although no drugs currently target NRK specifically, its functional roles suggest potential as a therapeutic target, especially in diseases involving cell signaling, development, or proliferation[3][4][6].
Not established; potential mechanisms could include kinase inhibition or modulation of the Akt or JNK pathways
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Nik-related protein kinase (NRK).